New Product Launch: NGS Unique-Dual Indexed Stubby Adapter Kits
For years, Oligo Factory has supplied critical oligonucleotides to NGS platform and genomics tools providers as a trusted OEM manufacturing partner.
Inspirata AI Unveils Rebrand Backed by Two Decades of Cancer Registry Innovation and a Deepened Partnership with ONCO Inc.
TAMPA, Fla., July 16, 2026 /PRNewswire/ — Inspirata today announced it has rebranded as Inspirata AI, marking a new chapter powered by enhanced, native AI-driven cancer casefinding, data abstraction, and reporting capabilities and a strengthened partnership with ONCO Inc.
Quetzal Therapeutics Announces First Patient Dosed in Phase 3 QUATRO-APL Trial of QTX-2101 for Frontline Acute Promyelocytic Leukemia
CHICAGO, June 11, 2026 (GLOBE NEWSWIRE) — Quetzal Therapeutics, a biopharmaceutical company focused on developing therapies for rare hematologic…
Advaita Bio Launches iSCanGuide™: Unified Single-Cell and Spatial Transcriptomics Analysis, Powered by GPU-Accelerated Infrastructure
Advaita Bio was awarded $1.7M from the National Institute of Health (NIH) to develop a new platform for the analysis of single-cell data.
Singular Genomics Names John Stark as Chief Executive Officer as Company Builds on Spatial Platform Momentum
/PRNewswire/ — Singular Genomics Systems, Inc. today announced the appointment of John Stark as Chief Executive Officer. This leadership transition comes as…
Nomic and Broad Clinical Labs Partner to Integrate Omni 1000 into Discovery and Translational Workflows
Nomic Bio today announced a partnership with Broad Clinical Labs (BCL) to integrate the Nomic platform into its multi-omic workflows.
Plus Therapeutics Receives AMA PLA Code for CNSide® CSF Tumor Cell Enumeration Test, Advancing Reimbursement and U.S. Commercial Adoption
New dedicated billing code facilitates payer reimbursement, supports clinician adoptions, and enables national utilization tracking HOUSTON, April 07, 2026 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a healthcare company developing and commercializing
n6 Launches icon16™, Expanding AutoNorm™ Adaptive Amplification to Lower-Throughput NGS Workflows
/PRNewswire/ — In 2024, n6 introduced icon96™, redefining expectations for PCR amplification in NGS library preparation. By monitoring each well in real time
Candel Therapeutics Reports Extended Survival Tail Observed in Trial of Aglatimagene Besadenovec (CAN-2409) in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response to Immune Checkpoint Inhibitors
Candel Therapeutics reports 50% of advanced NSCLC patients survived beyond 24 months with aglatimagene after inadequate response to immune checkpoint inhibitors.
Singular Genomics Names the Spatial Technologies Unit at Beth Israel Deaconess Medical Center a G4X™ Center of Excellence
Singular Genomics designates BIDMC’s Spatial Technologies Unit a G4X™ Center of Excellence for spatial tissue profiling.